These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

383 related items for PubMed ID: 9129161

  • 1. Regulation of bcl-xL expression and Fas susceptibility in mouse B cells by CD40 ligation, surface IgM crosslinking and IL-4.
    Koizumi T, Wang J, Suzuki Y, Masuda K, Watanabe T.
    Mol Immunol; 1996 Nov; 33(16):1247-53. PubMed ID: 9129161
    [Abstract] [Full Text] [Related]

  • 2. CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway.
    Schattner EJ, Elkon KB, Yoo DH, Tumang J, Krammer PH, Crow MK, Friedman SM.
    J Exp Med; 1995 Nov 01; 182(5):1557-65. PubMed ID: 7595225
    [Abstract] [Full Text] [Related]

  • 3. Up-regulation of Bcl-xL expression protects CD40-activated human B cells from Fas-mediated apoptosis.
    Zhang X, Li L, Choe J, Krajewski S, Reed JC, Thompson C, Choi YS.
    Cell Immunol; 1996 Oct 10; 173(1):149-54. PubMed ID: 8871610
    [Abstract] [Full Text] [Related]

  • 4. Role of the CD40 and CD95 (APO-1/Fas) antigens in the apoptosis of human B-cell malignancies.
    Wang D, Freeman GJ, Levine H, Ritz J, Robertson MJ.
    Br J Haematol; 1997 May 10; 97(2):409-17. PubMed ID: 9163608
    [Abstract] [Full Text] [Related]

  • 5. Ligation of CD40 potentiates Fas-mediated activation of the cysteine protease CPP32, cleavage of its death substrate PARP, and apoptosis in Ramos-Burkitt lymphoma B cells.
    An S, Yap D, Knox KA.
    Cell Immunol; 1997 Nov 01; 181(2):139-52. PubMed ID: 9398401
    [Abstract] [Full Text] [Related]

  • 6. Role of complement-binding CD21/CD19/CD81 in enhancing human B cell protection from Fas-mediated apoptosis.
    Mongini PK, Jackson AE, Tolani S, Fattah RJ, Inman JK.
    J Immunol; 2003 Nov 15; 171(10):5244-54. PubMed ID: 14607925
    [Abstract] [Full Text] [Related]

  • 7. Fas ligation induces apoptosis of CD40-activated human B lymphocytes.
    Garrone P, Neidhardt EM, Garcia E, Galibert L, van Kooten C, Banchereau J.
    J Exp Med; 1995 Nov 01; 182(5):1265-73. PubMed ID: 7595197
    [Abstract] [Full Text] [Related]

  • 8. Interleukin-13 in combination with CD40 ligand potently inhibits apoptosis in human B lymphocytes: upregulation of Bcl-xL and Mcl-1.
    Lømo J, Blomhoff HK, Jacobsen SE, Krajewski S, Reed JC, Smeland EB.
    Blood; 1997 Jun 15; 89(12):4415-24. PubMed ID: 9192766
    [Abstract] [Full Text] [Related]

  • 9. Induction of bcl-x by CD40 engagement rescues sIg-induced apoptosis in murine B cells.
    Wang Z, Karras JG, Howard RG, Rothstein TL.
    J Immunol; 1995 Oct 15; 155(8):3722-5. PubMed ID: 7561075
    [Abstract] [Full Text] [Related]

  • 10. CD40-ligation-mediated protection from apoptosis of a Fas-sensitive Hodgkin's-disease-derived cell line.
    Metkar SS, Naresh KN, Redkar AA, Nadkarni JJ.
    Cancer Immunol Immunother; 1998 Oct 15; 47(2):104-12. PubMed ID: 9769119
    [Abstract] [Full Text] [Related]

  • 11. Ectopic expression of Bcl-2, but not Bcl-xL rescues Ramos B cells from Fas-mediated apoptosis.
    Alam MK, Davison S, Siddiqui N, Norton JD, Murphy JJ.
    Eur J Immunol; 1997 Dec 15; 27(12):3485-91. PubMed ID: 9464838
    [Abstract] [Full Text] [Related]

  • 12. An essential role for Bruton's [corrected] tyrosine kinase in the regulation of B-cell apoptosis.
    Anderson JS, Teutsch M, Dong Z, Wortis HH.
    Proc Natl Acad Sci U S A; 1996 Oct 01; 93(20):10966-71. PubMed ID: 8855292
    [Abstract] [Full Text] [Related]

  • 13. CD40 inhibits B cell apoptosis by upregulating bcl-xL expression and blocking oxidant accumulation.
    Fang W, Nath KA, Mackey MF, Noelle RJ, Mueller DL, Behrens TW.
    Am J Physiol; 1997 Mar 01; 272(3 Pt 1):C950-6. PubMed ID: 9124531
    [Abstract] [Full Text] [Related]

  • 14. Modulation of anti-IgM-induced B cell apoptosis by Bcl-xL and CD40 in WEHI-231 cells. Dissociation from cell cycle arrest and dependence on the avidity of the antibody-IgM receptor interaction.
    Merino R, Grillot DA, Simonian PL, Muthukkumar S, Fanslow WC, Bondada S, Núñez G.
    J Immunol; 1995 Oct 15; 155(8):3830-8. PubMed ID: 7561089
    [Abstract] [Full Text] [Related]

  • 15. Regulation of the Fas death pathway by FLICE-inhibitory protein in primary human B cells.
    Hennino A, Berard M, Casamayor-Pallejà M, Krammer PH, Defrance T.
    J Immunol; 2000 Sep 15; 165(6):3023-30. PubMed ID: 10975811
    [Abstract] [Full Text] [Related]

  • 16. Germinal center-derived signals act with Bcl-2 to decrease apoptosis and increase clonogenicity of drug-treated human B lymphoma cells.
    Walker A, Taylor ST, Hickman JA, Dive C.
    Cancer Res; 1997 May 15; 57(10):1939-45. PubMed ID: 9157989
    [Abstract] [Full Text] [Related]

  • 17. The role of bcl-XL in CD40-mediated rescue from anti-mu-induced apoptosis in WEHI-231 B lymphoma cells.
    Choi MS, Boise LH, Gottschalk AR, Quintans J, Thompson CB, Klaus GG.
    Eur J Immunol; 1995 May 15; 25(5):1352-7. PubMed ID: 7539757
    [Abstract] [Full Text] [Related]

  • 18. Bcl-x protects primary B cells against Fas-mediated apoptosis.
    Schneider TJ, Grillot D, Foote LC, Núñez GE, Rothstein TL.
    J Immunol; 1997 Nov 15; 159(10):4834-9. PubMed ID: 9366408
    [Abstract] [Full Text] [Related]

  • 19. B-cell receptor and Fas-mediated signals for life and death.
    Carey GB, Donjerković D, Mueller CM, Liu S, Hinshaw JA, Tonnetti L, Davidson W, Scott DW.
    Immunol Rev; 2000 Aug 15; 176():105-15. PubMed ID: 11043771
    [Abstract] [Full Text] [Related]

  • 20. Distinct molecular mechanisms of Fas resistance in murine B lymphoma cells.
    Mueller CM, Scott DW.
    J Immunol; 2000 Aug 15; 165(4):1854-62. PubMed ID: 10925264
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.